YIGSR modified curcumin, preparation method, biological activity and application thereof

A kind of curcumin, base curcumin technology, applied in YIGSR modified curcumin, its preparation, biological activity and application field

Active Publication Date: 2017-01-11
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, these compounds disclosed by the inventors are not compounds with anti-tumor, anti-cancer metastasis, anti-inflammation and anti-thrombotic effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • YIGSR modified curcumin, preparation method, biological activity and application thereof
  • YIGSR modified curcumin, preparation method, biological activity and application thereof
  • YIGSR modified curcumin, preparation method, biological activity and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 Preparation of (E)-6-(4-hydroxyl-3-methoxyphenyl)hex-5-ene-2,4-dione

[0029] Dissolve 30 mL (100.0 mmol) of acetylacetone in 200 mL of ethyl acetate, and heat and stir at 60°C. While stirring, add 12.6g (200mmol) boric anhydride (B 2 o 3 ) and stirred for 1 hour. Then 27mL (100.0mmol) tri-n-butyl borate and 15.6g (100.0mmol) vanillin were added, and heated to 70°C for 30min. Afterwards, 10 mL of n-butylamine was diluted to 100 mL with ethyl acetate and slowly added to the reaction and heated to 100° C. for 2 hours. After the reaction was completed, the temperature was lowered to 60°C and 100 mL of 2N hydrochloric acid was added and stirred for 30 minutes. After the precipitate is fully separated, filter the precipitate and put it in a separatory funnel. Wash three times with saturated potassium bisulfate and saturated sodium chloride respectively. Ethyl acetate layer with anhydrous Na 2 SO 4 Let dry for 12 hours. After filtration, the filtrate was co...

Embodiment 2

[0030] Example 2 Preparation of benzyl-2-(4-formyl-2-methoxyphenoxy) ethyl acetate

[0031] Dissolve 15.6g (100.0mmol) of vanillin in 100mL of anhydrous tetrahydrofuran, add 8.2g (60mmol) of potassium carbonate and stir for 2 hours. Subsequently, 17.4 mL (120 mol) of benzyl bromoacetate was added, and the reaction was heated at 60° C. for 3 days. After the raw material disappeared, the insoluble matter was filtered off, and the filtrate was concentrated under reduced pressure to remove THF. The residue was crystallized from diethyl ether to afford 20.6 g (69%) of the title compound as a colorless solid. ESI + -MS(m / e): 301[M+H] + .

Embodiment 3

[0032] Example 3 Preparation of Benzyl 2-{4-[(1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-diene-1 -yl]-2-methoxyphenoxy}ethyl acetate

[0033] Dissolve 10 g (42.7 mmol) of (E)-6-(4-hydroxy-3-methoxyphenyl)hex-5-ene-2,4-dione in 100 mL of ethyl acetate, and heat and stir at 60°C. While stirring, add 5.4g (85.4mmol) boric anhydride (B 2 o 3 ), stirred for 1 hour. Then 12mL (42.7mmol) of tri-n-butyl borate and 6.7g (42.7mmol) of ethyl benzyl-2-(4-formyl-2-methoxyphenoxy)acetate were added, and the reaction was heated at 70°C for 30min. After that, a solution of 4.2 mL of n-butylamine and 50 mL of ethyl acetate was added slowly. The temperature was raised to 100° C. for 2 hours. After the reaction was completed, the temperature was lowered to 60°C, 42mL of 2N hydrochloric acid was added, and stirred for 30 minutes. After the precipitate was fully separated, the precipitate was filtered off. The filtrate was washed three times with saturated potassium bisulfate a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a curcumin and oligopeptide Tyr-Ile-Gly-Ser-Arg conjugate of the following formula, a preparation method thereof, its activity of inhibiting tumor cell proliferation, its effect of inhibiting migration and invasion of A549 cells, its activity of inhibiting S180 tumor-bearing mice tumor weight increase, its activity of inhibiting Lewis lung cancer metastasis, its activity of inhibiting xylene induced mice ear swelling, and further discloses its activity of inhibiting rat thrombosis.

Description

technical field [0001] The present invention relates to a conjugate of curcumin and oligopeptide Tyr-Ile-Gly-Ser-Arg, to its preparation method, to its anti-tumor cell proliferation activity, to its ability to inhibit the migration and invasion of A549 cells, to its Its activity of inhibiting tumor growth in S180 tumor-bearing mice relates to its activity of inhibiting the metastasis of Lewis lung cancer, further relates to its activity of inhibiting xylene-induced ear swelling in mice, and further relates to its activity of inhibiting thrombosis in rats. The invention belongs to the field of biomedicine. Background technique [0002] Malignant tumors are a serious threat to human health. The mortality rate of malignant tumors is second only to cardiovascular and cerebrovascular diseases, ranking second among all diseases. Most patients with malignant tumors are accompanied by metastasis, inflammation and thrombus. Cancer metastasis, inflammation and thrombus make tumor pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06C07K1/06A61K38/08A61P35/00A61P35/04A61P29/00
CPCY02P20/55
Inventor 彭师奇赵明王渊璟胡西
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap